Chongqing Pharscin Pharmaceutical Co Ltd
002907
Company Profile
Business description
Chongqing Pharscin Pharmaceutical Co Ltd is a China-based pharmaceutical research and development company. It produces and sells medicines in form of tablets, powders, granules, hard capsules, soft capsules, powder injection, freeze-dried powder injection, small volume injection, raw material synthesis and botanical extracts. It operates internationally.
Contact
No. 89, Middle Section of Huangshan Avenue
Yubei District
Chongqing401120
CHNT: +86 2367622999
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,384
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,206.07 | 17.48 | 0.21% |
| DAX 40 | 24,258.80 | 427.81 | 1.80% |
| Dow JONES (US) | 46,722.18 | 531.57 | 1.15% |
| FTSE 100 | 9,403.57 | 49.00 | 0.52% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 23,015.84 | 335.86 | 1.48% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,739.38 | 75.37 | 1.13% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |